MPWM Advisory Solutions’s GSK GSK Stock Holding History

MPWM Advisory Solutions’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-43	Closed	-$1.67K	–	624
2025 Q1	$1.67K	Hold	43	–	–	﹤0.01%	485
2024 Q4	$1.45K	Buy	+43	New	+$1.55K	﹤0.01%	505

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return

MPWM Advisory Solutions's GSK Position: Q2 2025 in Review

MPWM Advisory Solutions sold out of GSK (GSK) in Q2 2025, closing a stake of 43 shares — an estimated $1.67K sold.

MPWM Advisory Solutions first reported a position in GSK in Q4 2024 and held it in 2 quarters. The position peaked at $1.67K in Q1 2025. 890 funds tracked by Wall St. Rank hold GSK as of Q2 2025.

MPWM Advisory Solutions reported no remaining GSK position as of Q2 2025 after selling out during the quarter.
MPWM Advisory Solutions sold 43 GSK shares in Q2 2025, an estimated $1.67K.
MPWM Advisory Solutions first reported a position in GSK in Q4 2024 and held it in 2 quarters.
MPWM Advisory Solutions's GSK position peaked at $1.67K in Q1 2025.
890 funds tracked by Wall St. Rank held GSK as of Q2 2025.

Based on MPWM Advisory Solutions's 13F filing for Q2 2025, filed 14 Aug 2025.